Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
5.82
+0.11 (1.93%)
Sep 30, 2026, 4:08 PM HKT
HKG:0719 Market Cap
HKG:0719 has a market cap or net worth of 9.7 billion as of October 1, 2026. Its market cap has decreased by -1.47% in one year.
Market Cap
9.70B
Enterprise Value
9.87B
Revenue
9.78B
Ranking
n/a
PE Ratio
16.22
Stock Price
5.82
ChartMarket Cap Chart
Since January 3, 2000, HKG:0719's market cap has increased from 282.03M to 9.70B, an increase of 3,340.24%. That is a compound annual growth rate of 14.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 9.70B | -0.69% |
| Dec 31, 2025 | 9.77B | 5.26% |
| Dec 31, 2024 | 9.28B | -21.98% |
| Dec 29, 2023 | 11.90B | -32.94% |
| Dec 30, 2022 | 17.74B | 159.14% |
| Dec 31, 2021 | 6.85B | 25.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grand Pharmaceutical Group | 17.26B |
| The United Laboratories International Holdings | 15.67B |
| Fujian Haixi Pharmaceuticals | 13.07B |
| Consun Pharmaceutical Group | 12.45B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| SSY Group | 8.17B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 7.97B |
| Luye Pharma Group | 7.57B |